Background Computer-aided detection (CADe) has been developed to improve detection during colonoscopy. After initial reports of high efficacy, there has been an increasing recognition of variability in the effectiveness of CADe systems. The aim of this study was to evaluate a CADe system in a varied colonoscopy population. Methods A multicenter, randomized trial was conducted at seven hospitals (both university and non-university) in Europe and Canada. Participants referred for diagnostic, non-immunochemical fecal occult blood test (iFOBT) screening, or surveillance colonoscopy were randomized (1:1) to undergo CADe-assisted or conventional colonoscopy by experienced endoscopists. Participants with insufficient bowel preparation were excluded from the analysis. The primary outcome was adenoma detection rate (ADR). Secondary outcomes included adenomas per colonoscopy (APC) and sessile serrated lesions (SSLs) per colonoscopy. Results 581 participants were enrolled, of whom 497 were included in the final analysis: 250 in the CADe arm and 247 in the conventional colonoscopy arm. The indication was surveillance in 202/497 colonoscopies (40.6 %), diagnostic in 199/497 (40.0 %), and non-iFOBT screening in 96/497 (19.3 %). Overall, ADR (38.4 % vs. 37.7 %; P = 0.43) and APC (0.66 vs. 0.66; P = 0.97) were similar between CADe and conventional colonoscopy. SSLs per colonoscopy was increased (0.30 vs. 0.19; P = 0.049) in the CADe arm vs. the conventional colonoscopy arm. Conclusions In this study conducted by experienced endoscopists, CADe did not result in a statistically significant increase in ADR. However, the ADR of our control group substantially surpassed our sample size assumptions, increasing the risk of an underpowered trial.
Guidelines are equivocal on the need for early surveillance colonoscopy (ESC) after piecemeal endoscopic mucosal resection (pEMR) of 10–20-mm nonpedunculated colorectal polyps (NPCPs). This study assessed recurrence rates and associated factors at ESC following hot-snare pEMR of 10–20-mm NPCPs.A retrospective, multicenter cohort study was performed at five hospitals in the Netherlands. Patients undergoing pEMR of 10–20-mm NPCPs (2014–2021) and referred for ESC (range 3–9 months) were included. The primary outcome was recurrence rate at ESC. Secondary outcomes included scar identification rates, both overall and at tattooed sites. A mixed-effects model was used to identify factors associated with recurrence.389 patients undergoing pEMR of 426 NPCPs 10–20 mm (median 15 mm, interquartile range 12.8–20.0 mm) were included. Overall, 262 scars (61.5%; 95%CI 56.8–66.0) and 81.6% of tattooed sites were identified at ESC. The recurrence rate was 35/426 (8.2%; 95%CI 6.0–11.2) overall and 35/262 (13.4%; 95%CI 9.8–18.0) when the scar was identified. Median recurrence size was 5 mm, without high grade dysplasia. No NPCP characteristics were associated with recurrence.This real-world study found a substantial recurrence rate after hot-snare pEMR of NPCPs sized 10–20mm at ESC. ESC scar identification was moderate but improved with tattoo placement. Although early surveillance could be considered to avoid missing recurrence, the small recurrence size and absence of high grade dysplasia suggest that modestly extending the interval beyond that of our study may still allow timely detection of recurrences and metachronous lesions.
9 December 2025 in Clinical and Translational Gastroenterology
INTRODUCTION: Mucosal exposure devices (MEDs) and computer-aided detection (CADe) systems may both improve adenoma detection through distinct mechanisms: expanding mucosal visualization and highlighting lesions, respectively. This study investigated the efficacy of combining CADe-assisted colonoscopy with a MED compared with CADe-assisted colonoscopy alone. METHODS: This international, multicenter, prospective, nonrandomized, single-arm study (NTC05220345) was conducted at 3 centers that also participated in the previous DISCOVERY II randomized controlled trial, comparing CADe-assisted with conventional colonoscopy. Eligible participants were patients referred for diagnostic, nonfecal immunochemical test screening, or surveillance colonoscopy and underwent CADe-assisted colonoscopy (DISCOVERY, PENTAX Medical) with a MED using an integrated inflatable balloon (G-EYE, SMART Medical Systems). The primary outcome was adenoma detection rate (ADR); secondary outcomes included sessile serrated lesion detection rate and withdrawal time without interventions. Outcomes were compared with historical controls of the CADe-arm of the DISCOVERY II study. RESULTS: Of 196 enrolled participants, 182 were included in the final analysis and compared with 250 participants from the historical CADe-arm. ADR was 47.3% in the CADe + MED-group vs 38.4% in the CADe-group ( P = .066; absolute difference: 8.9%, 95% confidence interval: 0.6–18.3). Mixed-effects logistic regression model adjusting for clustering and confounders calculated an odds ratio of 1.16 (95% confidence interval: 0.74–1.81). Median withdrawal time was slightly longer with CADe + MED compared with CADe-only (10.0 vs 9.2 minutes, P = 0.004), whereas sessile serrated lesion detection rate was not significantly different (12.6% vs 18.4%, P = 0.11). DISCUSSION: In this study using historical controls, CADe-assisted colonoscopy combined with a MED did not significantly increase ADR compared with CADe alone, suggesting limited synergistic benefit.